These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 30761386)

  • 1. Evolving Intersection Between Inherited Cancer Genetics and Therapeutic Clinical Trials in Prostate Cancer: A White Paper From the Germline Genetics Working Group of the Prostate Cancer Clinical Trials Consortium.
    Carlo MI; Giri VN; Paller CJ; Abida W; Alumkal JJ; Beer TM; Beltran H; George DJ; Heath EI; Higano CS; McKay RR; Morgans AK; Patnaik A; Ryan CJ; Schaeffer EM; Stadler WM; Taplin ME; Kauff ND; Vinson J; Antonarakis ES; Cheng HH
    JCO Precis Oncol; 2018; 2018():. PubMed ID: 30761386
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Germline Genetic Testing in Advanced Prostate Cancer; Practices and Barriers: Survey Results from the Germline Genetics Working Group of the Prostate Cancer Clinical Trials Consortium.
    Paller CJ; Antonarakis ES; Beer TM; Borno HT; Carlo MI; George DJ; Graff JN; Gupta S; Heath EI; Higano CS; McKay RR; Morgans AK; Patnaik A; Petrylak DP; Rettig MB; Ryan CJ; Taplin ME; Whang YE; Vinson J; Cheng HH; Giri VN;
    Clin Genitourin Cancer; 2019 Aug; 17(4):275-282.e1. PubMed ID: 31171481
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bringing Prostate Cancer Germline Genetics into Clinical Practice.
    Das S; Salami SS; Spratt DE; Kaffenberger SD; Jacobs MF; Morgan TM
    J Urol; 2019 Aug; 202(2):223-230. PubMed ID: 30730411
    [TBL] [Abstract][Full Text] [Related]  

  • 4. American Society of Clinical Oncology policy statement update: genetic testing for cancer susceptibility.
    American Society of Clinical Oncology
    J Clin Oncol; 2003 Jun; 21(12):2397-406. PubMed ID: 12692171
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Implementation of Germline Testing for Prostate Cancer: Philadelphia Prostate Cancer Consensus Conference 2019.
    Giri VN; Knudsen KE; Kelly WK; Cheng HH; Cooney KA; Cookson MS; Dahut W; Weissman S; Soule HR; Petrylak DP; Dicker AP; AlDubayan SH; Toland AE; Pritchard CC; Pettaway CA; Daly MB; Mohler JL; Parsons JK; Carroll PR; Pilarski R; Blanco A; Woodson A; Rahm A; Taplin ME; Polascik TJ; Helfand BT; Hyatt C; Morgans AK; Feng F; Mullane M; Powers J; Concepcion R; Lin DW; Wender R; Mark JR; Costello A; Burnett AL; Sartor O; Isaacs WB; Xu J; Weitzel J; Andriole GL; Beltran H; Briganti A; Byrne L; Calvaresi A; Chandrasekar T; Chen DYT; Den RB; Dobi A; Crawford ED; Eastham J; Eggener S; Freedman ML; Garnick M; Gomella PT; Handley N; Hurwitz MD; Izes J; Karnes RJ; Lallas C; Languino L; Loeb S; Lopez AM; Loughlin KR; Lu-Yao G; Malkowicz SB; Mann M; Mille P; Miner MM; Morgan T; Moreno J; Mucci L; Myers RE; Nielsen SM; O'Neil B; Pinover W; Pinto P; Poage W; Raj GV; Rebbeck TR; Ryan C; Sandler H; Schiewer M; Scott EMD; Szymaniak B; Tester W; Trabulsi EJ; Vapiwala N; Yu EY; Zeigler-Johnson C; Gomella LG
    J Clin Oncol; 2020 Aug; 38(24):2798-2811. PubMed ID: 32516092
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Germline mutations and prostate cancer: is it time to change treatment algorithms?
    Telvizian T; Mukherji D
    Chin Clin Oncol; 2020 Oct; 9(5):65. PubMed ID: 32921062
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Technology-enhanced AcceleRation of Germline Evaluation for Therapy (TARGET): A randomized controlled trial of a pretest patient-driven webtool vs. genetic counseling for prostate cancer germline testing.
    Loeb S; Cheng HH; Leader A; Gross L; Nolasco TS; Byrne N; Wise DR; Hollifield L; Brown LH; Slater E; Pieczonka C; Gomella LG; Kelly WK; Trabulsi EJ; Handley N; Lallas CD; Chandrasekar T; Mille P; Mann M; Mark JR; Brown G; Chopra S; Wasserman J; Phillips J; Somers P; Giri VN
    Contemp Clin Trials; 2022 Aug; 119():106821. PubMed ID: 35710085
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mainstream germline genetic testing in men with metastatic prostate cancer: design and protocol for a multicenter observational study.
    Vlaming M; Bleiker EMA; van Oort IM; Kiemeney LALM; Ausems MGEM
    BMC Cancer; 2022 Dec; 22(1):1365. PubMed ID: 36581909
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prostate cancer: germline prediction for a commonly variable malignancy.
    Bambury RM; Gallagher DJ
    BJU Int; 2012 Dec; 110(11 Pt C):E809-18. PubMed ID: 22974436
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pretest Genetic Education Video Versus Genetic Counseling for Men Considering Prostate Cancer Germline Testing: A Patient-Choice Study to Address Urgent Practice Needs.
    Russo J; McDougall C; Bowler N; Shimada A; Gross L; Hyatt C; Kelly WK; Calvaresi A; Handley NR; Hirsch IH; Izes JK; Lallas CD; Mann M; Mark JR; Mille PJ; Preate D; Trabulsi EJ; Tsang M; Chandrasekar T; Weiner PR; Gomella LG; Giri VN
    JCO Precis Oncol; 2021; 5():. PubMed ID: 34589662
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Germline genetic testing for inherited prostate cancer in practice: Implications for genetic testing, precision therapy, and cascade testing.
    Giri VN; Hegarty SE; Hyatt C; O'Leary E; Garcia J; Knudsen KE; Kelly WK; Gomella LG
    Prostate; 2019 Mar; 79(4):333-339. PubMed ID: 30450585
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic testing practices among specialist physicians who treat prostate cancer A Canadian, cross-sectional survey.
    Yip SM; Morash C; Kolinsky MP; Kapoor A; Ong M; Selvarajah S; Nuk J; Compton K; Pouliot F; Lavallée LT; Khalaf DJ; Hamilton RJ; Gotto GT; Rendon RA; Antebi E; Hotte SJ; Malone S; Chi KN; Drachenberg DE; Saad F; Chan J; Ferrario C; Ko J; Shayegan B; Parimi S; So AI; Feifer A; Jansz K; Finch D; Chin JL; Osborne B; Ho KF; Galamo CD; Zardan A; Niazi T
    Can Urol Assoc J; 2023 Oct; 17(10):326-336. PubMed ID: 37494316
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetics in prostate cancer: implications for clinical practice.
    Szymaniak B; Ross AE; Morgans AK
    Curr Opin Support Palliat Care; 2021 Dec; 15(4):241-246. PubMed ID: 34762074
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Practical Methods for Integrating Genetic Testing Into Clinical Practice for Advanced Prostate Cancer.
    Cheng H; Powers J; Schaffer K; Sartor O
    Am Soc Clin Oncol Educ Book; 2018 May; 38():372-381. PubMed ID: 30231311
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Germline Genetics of Prostate Cancer: Prevalence of Risk Variants and Clinical Implications for Disease Management.
    Doan DK; Schmidt KT; Chau CH; Figg WD
    Cancers (Basel); 2021 Apr; 13(9):. PubMed ID: 33947030
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Outcomes of a universal germline screening program in a community urology practice.
    Mendhiratta N; Hauver H; Hatton W; Ostrusky A; Sathe DS; Gurram S; Rice P; Chalfin H
    Clin Genet; 2024 May; ():. PubMed ID: 38711401
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intraductal/ductal histology and lymphovascular invasion are associated with germline DNA-repair gene mutations in prostate cancer.
    Isaacsson Velho P; Silberstein JL; Markowski MC; Luo J; Lotan TL; Isaacs WB; Antonarakis ES
    Prostate; 2018 Apr; 78(5):401-407. PubMed ID: 29368341
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Practical Considerations and Challenges for Germline Genetic Testing in Patients With Prostate Cancer: Recommendations From the Germline Genetics Working Group of the PCCTC.
    Szymaniak BM; Facchini LA; Giri VN; Antonarakis ES; Beer TM; Carlo MI; Danila DC; Dhawan M; George D; Graff JN; Gupta S; Heath E; Higano CS; Liu G; Molina AM; Paller CJ; Patnaik A; Petrylak DP; Reichert Z; Rettig MB; Ryan CJ; Taplin ME; Vinson J; Whang YE; Morgans AK; Cheng HH; McKay RR
    JCO Oncol Pract; 2020 Dec; 16(12):811-819. PubMed ID: 32986533
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mutation Detection in Patients With Advanced Cancer by Universal Sequencing of Cancer-Related Genes in Tumor and Normal DNA vs Guideline-Based Germline Testing.
    Mandelker D; Zhang L; Kemel Y; Stadler ZK; Joseph V; Zehir A; Pradhan N; Arnold A; Walsh MF; Li Y; Balakrishnan AR; Syed A; Prasad M; Nafa K; Carlo MI; Cadoo KA; Sheehan M; Fleischut MH; Salo-Mullen E; Trottier M; Lipkin SM; Lincoln A; Mukherjee S; Ravichandran V; Cambria R; Galle J; Abida W; Arcila ME; Benayed R; Shah R; Yu K; Bajorin DF; Coleman JA; Leach SD; Lowery MA; Garcia-Aguilar J; Kantoff PW; Sawyers CL; Dickler MN; Saltz L; Motzer RJ; O'Reilly EM; Scher HI; Baselga J; Klimstra DS; Solit DB; Hyman DM; Berger MF; Ladanyi M; Robson ME; Offit K
    JAMA; 2017 Sep; 318(9):825-835. PubMed ID: 28873162
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PROMISE Registry: A prostate cancer registry of outcomes and germline mutations for improved survival and treatment effectiveness.
    Paller CJ; Barata PC; Lorentz J; Appleman LJ; Armstrong AJ; DeMarco TA; Dreicer R; Elrod JAB; Fleming M; George C; Heath EI; Hussain MHA; Mao S; McKay RR; Morgans AK; Orton M; Pili R; Riedel E; Saraiya B; Sigmond J; Sokolova A; Stadler WM; Tran C; Macario N; Vinson J; Green R; Cheng HH;
    Prostate; 2024 Feb; 84(3):292-302. PubMed ID: 37964482
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.